Last week, the United States Department of Justice issued an order moving FDA-approved marijuana products, as well as state-licensed medical marijuana products, to Schedule III of the Controlled Substances Act (CSA), implementing President Trump’s December 18, 2025, Executive Order.
| less than a minute read
Cannabis Rescheduling: What Does It Mean for Your Intellectual Property
Latest Insights
/Passle/684c7d72fa5dee4bb58c5944/SearchServiceImages/2026-04-29-14-53-48-587-69f21b7c7020cf8f43b3ae05.jpg)
/Passle/684c7d72fa5dee4bb58c5944/SearchServiceImages/2026-04-29-14-30-02-284-69f215ea7020cf8f43b39448.jpg)
/Passle/684c7d72fa5dee4bb58c5944/SearchServiceImages/2026-04-24-13-33-29-799-69eb7129ff7abc9eb9e14b91.jpg)
/Passle/684c7d72fa5dee4bb58c5944/MediaLibrary/Images/2026-04-22-15-48-41-410-69e8edd98321125fe1ed1244.png)